Management of Renal Cell Carcinoma—Current Practice in Sub-Saharan Africa

Main Article Content

Ayun Cassell
Mohamed Jalloh
Bashir Yunusa
Medina Ndoye
Mouhamadou M. Mbodji
Abdourahmane Diallo
Saint Charles Kouka
Issa Labou
Lamine Niang
Serigne M. Gueye

Keywords

immuotherapy, management, radical nephrectomy, renal cell carcinoma, sub-saharan africa

Abstract

There is a global variation in the incidence of renal masses with the developed nations having a greater incidence. About 80–90% of renal malignancies are renal cell carcinomas (RCC) which account for 2–4% of all cancers. In Africa and the Middle East, the age-standardized incidence for RCC is 1.8–4.8/100,000 for males and 1.2–2.2/100,000 for females. The management of renal cell cancer is challenging. A multidisciplinary approach is effective for diagnosis, staging, and treatment. Guidelines recommend active surveillance, thermal ablation, partial nephrectomy, radical nephrectomy, cytoreductive nephrectomy and immunotherapy as various modalities for various stages of RCC. However, open radical nephrectomy is most widely adopted as an option for treatment at various stages of the disease in sub-Saharan Africa due to its cost-effectiveness, applicability at various stages, and the reduced cost of follow-up. Nevertheless, most patients in the region present with the disease in the advanced stage and despite surgery the prognosis is poor.

Abstract 2051 | PDF Downloads 841 HTML Downloads 337 XML Downloads 344

References

1. Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017 Sep;198(3):520–9. https://doi.org/10.1016/j.juro.2017.04.100
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359. https://doi.org/10.1002/ijc.29210
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018 Nov;68(6):394–424. https://doi.org/10.3322/caac.21492
4. Zekri J, Dreosti LM, Ghosn M, Hamada E, Jaloudi M, Khor-shid O, et al. Multidisciplinary management of clear-cell renal cell carcinoma in Africa and the Middle East: Current practice and recommendations for improvement. J Multidiscip Health-care. 2015;8:335. https://doi.org/10.2147/JMDH.S85538
5. Atanda AT, Haruna MS. Renal cell carcinoma in Nigeria: A systematic review. Sahel Med J. 2017 Oct 1;20(4):137. https://doi.org/10.4103/smj.smj_67_16
6. Rashidkhani B, Akesson A, Lindblad P. Alcohol consumption and risk of renal cell carcinoma: A prospective study of Swedish women. Int J Cancer. 2005;117:848. https://doi.org/10.1002/ijc.21231
7. Lee JE, Mannisto S, Spiegelman D, Hunter DJ, Bernstein L, Van Den Brandt PA, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: A pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1730–9. https://doi.org/10.1158/1055-9965.EPI-09-0045
8. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5), 913–24. https://doi.org/10.1016/j.eururo.2015.01.005
9. Rendon RA, Kapoor A, Breau R, Leveridge M, Feifer A, Black PC, et al. Surgical management of renal cell carcinoma: Canadian kidney cancer forum consensus. Can Urol Assoc J. 2014 May;8(5–6): E398. https://doi.org/10.5489/cuaj.1894
10. Tengue K, Kpatcha TM, Sonhaye L. Cancer du rein de l’Adulte au Togo: Fréquence, diagnostic, traitement et évolution. Revue Africaine d’Urologie et d’Andrologie. 2015 Jul 2;1(4):177–82.
11. Fall B, Diao B, Sow Y, Sarr A, Thiam A, Fall PA, et al. Le can-cer du rein de l’adulte au Sénégal: Aspects épidémiologiques et cliniques actuels et évolution du profil sur les deux dernières décennies. Progrès en Urologie. 2011 Sep 1;21(8):521–6. https://doi.org/10.1016/j.purol.2011.02.013
12. Gueye SM, Diallo B, Fall PA, Ndoye AK, Konan PG, Abdallahi MO, et al. Malignant kidney tumors in adults in Senegal: Diagnostic and therapeutic problems. Dakar Med. 1998;43(2):213–15.
13. Ahmed M, Oyelowo N, Bello A, Lawal AT, Maitama HY, Abdul-salam K, et al. Peculiarities of renal cell carcinoma in young adults. Arch Int Surg. 2018;8:59–62. https://doi.org/10.4103/ais.ais_33_18
14. Tijani KH, Anunobi CC, Ezenwa EV, Lawal A, Habeebu MY, Jeje EA, et al. Adult renal cell carcinoma in Lagos: Experience and challenges at the Lagos University Teaching Hospital. African J Urol. 2012;18(1):20–3. https://doi.org/10.1016/j.afju.2012.04.005
15. Mbaeri TU, Orakwe JC, Nwafor AM, Oranusi CK, Ulebe AO. Malignant renal tumours in adults in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. Nigerian J Med. 2012;21(4):377–80.
16. Avakoudjo DG, Hounnasso PP, Traore MT, Natchagandé G, Pare AK, Tore-Sanni R, et al. Experience with managing solid kidney tumours in Cotonou, Benin Republic. J West Afr Coll Surg. 2014 Oct;4(4):100.
17. Coulibaly MT, Sissoko I, Berthé A, Amadou I, Traore B, Ly M, et al. Management of kidney cancers in Urology Department of the Gabriel Toure University Hospital/Bamako. Surg Sci. 2018 Jun 15;9(06):183. https://doi.org/10.4236/ss.2018.96021
18. Muhammed A, Ahmad B, Yusuf MH, Almustapha LA, Abdullahi S, Tijjani LA. Pathologic characteristics and management of renal cell carcinoma in Zaria, Nigeria. Sub-Saharan Afr J Med. 2015 Jan 1;2(1):1. https://doi.org/10.4103/2384-5147.151559
19. Badmus TA, Salako AB, Arogundade FA, Sanusi AA, Ade-sunkanmi AR, Oyebamiji EO, et al. Malignant renal tumors in adults: A ten-year review in a Nigerian hospital. Saudi J Kidney Dis Transpl. 2008 Jan 1;19(1):120.
20. Salako AA, Badmus TA, Badmos KB, David RA, Laoye A, Akinbola IA, et al. Renal cell carcinoma in a semi-urban population of south-western Nigeria. East Afr Med J. 2017 Jan;94(1):37–43.
21. Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, Iyoha E, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: Systematic review of the literature. J Urol. 2016;195(5):1340–7. https://doi.org/10.1016/j.juro.2015.11.029
22. Lane BR, Campbell SC, Gill IS. 10-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol. 2013;190:44–9. https://doi.org/10.1016/j.juro.2012.12.102
23. Fenn NJ, Gill IS. The expanding indications for laparoscopic radical nephrectomy. BJU Int. 2004;94:761–5. https://doi.org/10.1111/j.1464-410X.2004.05028.x
24. Woldrich JM, Palazzi K, Stroup SP, Sur RL, Parsons JK, Chang D, et al. Trends in the surgical management of localized renal masses: Thermal ablation, partial and radical nephrectomy in the USA, 1998-2008. BJU Int. 2013;111(8):1261–8. https://doi.org/10.1111/j.1464-410X.2012.11497.x
25. Steinberg AP, Finelli A, Desai MM, Abreu SC, Ramani AP, Spaliviero M, et al. Laparoscopic radical nephrectomy for large (greater than 7 cm, T2) renal tumours. J Urol. 2004;172(6 Part 1):2172–6. https://doi.org/10.1097/01.ju.0000140961.53335.04
26. Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, et al. Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. J Urol. 2011;185(1):37–42. https://doi.org/10.1016/j.juro.2010.08.084
27. Kletscher BA, Qian J, Bostwick DG, Blute ML, Zincke H. Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma. J Urol. 1996;155(6):1844–6. https://doi.org/10.1016/S0022-5347(01)66026-9
28. Margulis V, Sanchez-Ortiz RF, Tamboli P, Cohen DD, Swan-son DA, Wood CG. Renal cell carcinoma clinically involving adjacent organs: Experience with aggressive surgical management. Cancer. 2007;109(10):2025–30. https://doi.org/10.1002/cncr.22629
29. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumour stage, size, grade and necrosis: The SSIGN score. J Urol. 2002;168(6):2395–400. https://doi.org/10.1016/S0022-5347(05)64153-5
30. Flanigan RC, Mickisch G, Sylvester R, Tangen C, Van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis. J Urol. 2004;171(3):1071–6. https://doi.org/10.1097/01.ju.0000110610.61545.ae